Antibodies to NMDA receptor, blood-brain barrier disruption and schizophrenia: A theory with unproven links

Molecular Psychiatry

Volumn 19, Issue 10, 2014, Pages 1054-

  Titulaer, M J ^a,b   Dalmau, J ^a,c  

^a HOSPITAL CLÍNIC   (Spain)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; AUTOANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

BLOOD BRAIN BARRIER; BORDERLINE STATE; HUMAN; LETTER; MAJOR DEPRESSION; MOOD DISORDER; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SCHIZOPHRENIA; ANIMAL; BLOOD; FEMALE; IMMUNOLOGY; MALE; METABOLISM;

ANIMALS; AUTOANTIBODIES; BLOOD-BRAIN BARRIER; FEMALE; HUMANS; MALE; MOOD DISORDERS; PARKINSON DISEASE; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA;

EID: 84938678583     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2014.25     Document Type: Letter

References (5)

1. Hammer C, Stepniak B, Schneider A, Papiol S, Tantra M, Begemann M et al. Mol Psychiatry 2014; 19: 1143-1149.
2. Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R et al. J Neurosci 2010; 30: 5866-5875.
3. Moscato E, Peng XY, Parsons T, Dalmau J, Balice-Gordon R. J Neuroimmunol 2012; 253: 145 (abstract 408).
4. Steiner J, Walter M, Glanz W, Sarnyai Z, Bernstein HG, Vielhaber S et al. JAMA Psychiatry 2013; 70: 271-278.
5. Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F et al. Lancet Neurol 2013; 13: 167-177.